Literature DB >> 23707977

Systemic inflammatory responses and multiple organ dysfunction syndrome following skin burn wound and Pseudomonas aeruginosa infection in mice.

Na Li1, Xiaolong Hu, Yang Liu, Yaojun Wang, Yunchuan Wang, Jiaqi Liu, Weixia Cai, Xiaozhi Bai, Xiongxiang Zhu, Juntao Han, Dahai Hu.   

Abstract

Burn wound-related sepsis is associated with the development of systemic inflammatory response syndrome and multiple organ dysfunction syndrome (MODS). This study is aimed at investigating the development and progression of SIS and MODS in a mouse model of skin burn sepsis. C57BL/6J mice were randomly divided into the sham, burn, Pseudomonas, and burn/Pseudomonas groups. The back skin of the sham, burn, and burn/Pseudomonas groups was burned about 10% of total area with using 37°C or 98°C water for 8 s, respectively, followed by inoculating with Pseudomonas aeruginosa. The Pseudomonas group was infected with P. aeruginosa without burn injury. Their body weights, mortality, organ histology, and function as well as systemic inflammation were measured longitudinally. The burn/Pseudomonas mice lost more body weights than did mice from the other groups and had a significantly higher mortality rate (P < 0.05). The burn/Pseudomonas mice exhibited significantly higher levels of bacterial loads in different organs and serum endotoxin, interleukin 1β, interleukin 6, tumor necrosis factor α, and C-reactive protein than those in mice from the other groups (P < 0.05). The burn/Pseudomonas mice also displayed more severe liver, lung, and kidney tissue damage and impaired organ functions, particularly at 72 h after inoculation than did the burn and Pseudomonas groups of mice. Our data indicate that burn and P. aeruginosa infection induced severe sepsis and rapidly progressed into systemic inflammatory response syndrome and MODS in mice.

Entities:  

Mesh:

Year:  2013        PMID: 23707977     DOI: 10.1097/SHK.0b013e31829aef41

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

1.  Correlation of occurrence of infection in burn patients.

Authors:  N A Latifi; H Karimi
Journal:  Ann Burns Fire Disasters       Date:  2017-09-30

2.  Effects of resveratrol on the treatment of inflammatory response induced by severe burn.

Authors:  Ke Tao; Xiaozhi Bai; Wenbin Jia; Yang Liu; Xiongxiang Zhu; Juntao Han; Maolong Dong; Jun Li; Dongdong Chen; Dahai Hu
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Glutamine protects intestinal mucosa and promotes its transport after burn injury in rats.

Authors:  Yan Shi; Zi-En Wang; Wei Wu; Dan Wu; Chao Wang; Xi Peng
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Potential Use of Dimethyl Sulfoxide in Treatment of Infections Caused by Pseudomonas aeruginosa.

Authors:  Qiao Guo; Qiaolian Wu; Dangdang Bai; Yang Liu; Lin Chen; Sheng Jin; Yuting Wu; Kangmin Duan
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Early Growth Response 1 Deficiency Protects the Host against Pseudomonas aeruginosa Lung Infection.

Authors:  Zheng Pang; Renee Raudonis; Craig McCormick; Zhenyu Cheng
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

Review 6.  Choosing an appropriate infection model to study quorum sensing inhibition in Pseudomonas infections.

Authors:  Evelina Papaioannou; Putri Dwi Utari; Wim J Quax
Journal:  Int J Mol Sci       Date:  2013-09-23       Impact factor: 5.923

7.  Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection.

Authors:  Yang Liu; Qin Zhou; Yunchuan Wang; Zhengcai Liu; Maolong Dong; Yaojun Wang; Xiao Li; Dahai Hu
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Targeting the gut to prevent sepsis from a cutaneous burn.

Authors:  Fatemeh Adiliaghdam; Paul Cavallaro; Vidisha Mohad; Marianna Almpani; Florian Kühn; Mohammad Hadi Gharedaghi; Mehran Najibi; Laurence G Rahme; Richard A Hodin
Journal:  JCI Insight       Date:  2020-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.